Literature DB >> 12801138

HRCT findings of pulmonary complications in non-AIDS immunocompromised patients: are they useful in differential diagnosis?

Takuya Emoto1, Tsuneo Matsumoto, Nobuyuki Tanaka, Gouji Miura, Takeo Kawamura, Naofumi Matsunaga.   

Abstract

PURPOSE: This study was designed to evaluate the diagnostic value of characteristic HRCT findings in the differential diagnosis of acute pulmonary complications (APCs) in immunocompromised patients and to investigate how to improve diagnostic accuracy.
MATERIALS AND METHODS: We reviewed the chest CT images of 103 consecutive immunocompromised non-AIDS patients with APCs. The presence, extent, and anatomical distribution of the CT findings were assessed by two radiologists. The sensitivity and positive predictive value (PPV) of each criterion determined by the combination of CT findings that were characteristic in previous studies were calculated.
RESULTS: The average sensitivity of each criterion was 0.50 in the total cases. There were many false positives, and the PPVs of some criteria were low. Among the significantly less frequent CT findings, the frequency of bronchovascular bundle thickening was 0% in cytomegaloviral pneumonia (CMV P). The absence of this finding improved the diagnostic accuracy of CMV P.
CONCLUSION: Because the combination of only characteristic HRCT findings in each disease was of relatively limited value in making a diagnosis, infrequent findings should be also added to the CT criteria to improve accuracy.

Entities:  

Mesh:

Year:  2003        PMID: 12801138

Source DB:  PubMed          Journal:  Radiat Med        ISSN: 0288-2043


  1 in total

1.  Leukemic infiltration of the lung following allogeneic hematopoietic stem cell transplantation.

Authors:  Kazuhiko Kakihana; Kazuteru Ohashi; Fumikazu Sakai; Noriko Kamata; Yukio Hosomi; Mina Nishiwaki; Reiko Yokoyama; Takeshi Kobayashi; Takuya Yamashita; Hideki Akiyama; Hisashi Sakamaki
Journal:  Int J Hematol       Date:  2008-12-18       Impact factor: 2.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.